Changeflow GovPing Pharma & Drug Safety Pancreatic Cancer Detection Kit - Toray Industries
Routine Notice Added Final

Pancreatic Cancer Detection Kit - Toray Industries

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published application EP3988668A2 for a kit and method detecting early-stage pancreatic cancer and precursor lesions. Applicants are Toray Industries, Inc. and the National Cancer Center. The application covers all EPC contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR). The technology uses genetic detection methods classified under C12Q 1/68.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The EPO published patent application EP3988668A2 for a pancreatic cancer detection kit and detection method, filed by Toray Industries, Inc. and National Cancer Center. The application covers genetic detection methods (C12Q 1/68) for identifying early-stage pancreatic cancer and precursor lesions.

Affected parties including diagnostic manufacturers may review the technical disclosure via the EPO register. The application is under examination and has not yet been granted; no enforceable patent rights exist at this stage. Potential applicants in the diagnostic or biotech sector should monitor the application status for future grant decisions.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR

Publication EP3988668A2 Kind: A2 Apr 08, 2026

Applicants

Toray Industries, Inc., National Cancer Center

Inventors

KAWAUCHI, Junpei, SUDO, Hiroko, KOZONO, Satoko, OCHIAI, Atsushi, KOJIMA, Motohiro

IPC Classifications

C12Q 1/68 20180101AFI20220523BHEP C12M 1/00 20060101ALI20220523BHEP C12N 15/09 20060101ALI20220523BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3988668A2

Who this affects

Applies to
Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent filing Biotech R&D Diagnostics
Geographic scope
EP EP

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!